Objective: This prospective observational study aimed to evaluate the efficacy and safety of 0.75% ropivacaine administered via epidural neuraxial blockade for pain management in patients undergoing lower abdominal surgeries. Methods: A total of 100 adult patients scheduled for elective lower abdominal surgeries at the Indira Gandhi Institute of Medical Sciences, Patna, were enrolled in the study. Pain intensity, total postoperative opioid consumption, hemodynamic stability, adverse events, time to ambulation, and readiness for discharge were assessed as primary and secondary outcome measures. Results: Significant reductions in pain intensity scores were observed over time, with mean scores decreasing from 3.4 at 1 hour to 1.6 at 24 hours postoperatively. Median total opioid consumption was 12 mg (interquartile range: 8-16 mg), indicating moderate opioid requirements. Hemodynamic stability was maintained throughout the perioperative period, and no severe adverse events were reported. The median time to ambulation was 8 hours, with a median time to readiness for discharge of 12 hours. Conclusion: 0.75% ropivacaine epidural anesthesia demonstrated effective pain relief, opioid-sparing effects, hemodynamic stability, and a favorable safety profile in patients undergoing lower abdominal surgeries. This approach holds promise for optimizing perioperative care and promoting early recovery in this surgical population.